Henderson Molly - Insider Non-Derivative Transactions at Phathom Pharmaceuticals, Inc. (PHAT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 15, 2024, Henderson Molly's relationship to Phathom Pharmaceuticals, Inc. (PHAT) is Officer (CFO and CBO), and currently has 99,447 shares of Common Stock, and 102,763 shares of Common Stoock.

The the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PHAT insiders.

Data Source: SEC.
Henderson Molly - Insider Non-Derivative Transactions of PHAT Common Stock
Henderson Molly - Insider Non-Derivative Transactions of PHAT Common Stoock
Henderson Molly - Insider Non-Derivative Transactions at PHAT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 16, 2024 Sell -- (Common Stock) 4325 11.72 99447
Jun 1, 2024 Acquisition -- (Common Stoock) 7500 0 102763
Apr 9, 2024 Sell -- (Common Stoock) 3435 11.1 95263
Jan 20, 2024 Sell -- (Common Stock) 6307 7.75 98698
Nov 21, 2023 Sell -- (Common Stock) 2127 7.24 103061
Nov 2, 2023 Sell -- (Common Stock) 11681 8.95 105188
Nov 2, 2023 Sell -- (Common Stock) 811 7.8 116869
Nov 2, 2023 Acquisition -- (Common Stock) 22500 0 117680
Jul 15, 2023 Acquisition -- (Common Stock) 25000 0 95180
Jul 15, 2023 Acquisition -- (Common Stock) 25000 1 95180
Jun 3, 2023 Sell -- (Common Stock) 1960 11.41 68506
May 23, 2023 Sell -- (Common Stock) 2110 12.87 70466
Apr 7, 2023 Sell -- (Common Stock) 3439 7.27 72576
Mar 2, 2023 Sell -- (Common Stock) 2032 8.53 76015
Jan 20, 2023 Acquisition -- (Common Stock) 33000 0 78047